What Is the Estrobolome and How Does It Affect Estrogen Metabolism? | The Gut Estrogen Loop

The liver decides how much estrogen leaves your body. Your gut bacteria get a second vote — and that second vote is the estrobolome.

Estrogen your liver has already tagged for disposal travels through bile into the intestine, where certain microbes strip off that tag and send the hormone back into circulation. What the estrobolome is and how it affects estrogen metabolism comes down to that loop: a set of bacterial genes, a couple of workhorse enzymes, and the makeup of your gut community.

Researchers named the estrobolome to describe the microbial genes tied to estrogen handling, not a single organism you can buy in a bottle. The Maturitas review “Estrogen–gut microbiome axis: Physiological and clinical aspects” treats it as one half of a two-way conversation between hormones and gut bacteria, where each side shapes the other.

What The Estrobolome Actually Does

Two enzyme families do most of the work: bacterial β-glucuronidase removes the glucuronide tag your liver attached, and bacterial sulfatases convert sulfated estrogens into active forms. Neither enzyme creates estrogen. They only decide how much of the estrogen your body already made gets a second pass through your bloodstream.

The process has a name — enterohepatic recycling — and it is the reason gut bacteria can influence hormone levels at all. Estrogen that would otherwise leave your body in stool gets deconjugated, reabsorbed through the intestinal wall, and delivered back to the liver. Some of it circulates again.

A PMC review of gut microbial beta-glucuronidase describes the enzyme as a vital regulator in female hormone metabolism, and it is the piece most estrobolome research circles back to.

• Deconjugation: β-glucuronidase frees estrogen from its glucuronide form so it can be reabsorbed.
• Desulfation: sulfatases turn sulfated estrogen into a biologically active version.
• Phytoestrogen handling: gut microbes also convert plant estrogens into metabolites, including equol.

Does A Busy Estrobolome Mean Higher Estrogen?

More enzyme activity generally means more estrogen gets reactivated and reabsorbed, which pushes circulating estrogen up; less activity, or a disrupted gut community, pulls it down. That direction is well described in the literature. The size of the swing in a living person is where certainty drops off.

Anything that reshapes the gut community — diet, illness, antibiotics, aging — can change how much deconjugation happens. Reviews note that dysbiosis, a loss of microbial balance, tends to reduce estrogen recycling. Whether that shows up as symptoms you can feel is a different question, and one the research has not answered cleanly.

What The Research Shows — And Where It Stops

Reviews tie altered estrobolome function to breast cancer, endometrial cancer, polycystic ovary syndrome, endometriosis, infertility, and hepatocellular adenomas, but the human evidence is largely associative rather than definitive. A recent review states the estrobolome may influence hormone bioavailability and cancer risk while human evidence remains mostly correlational. Another adds a measurement problem: case-control findings were heterogeneous and showed limited alignment with estrobolome-specific targets.

Take that as a boundary rather than a dismissal. The mechanism holds up, the associations deserve study, and the leap from “associated with” to “causes” or “treats” has not been earned. No test measures your estrobolome in a way that guides treatment, which is why supplement claims about resetting it are running ahead of the science.

If you are comparing products that claim to target these bacteria, our roundup of estrobolome supplement options worth checking lays out what each formula contains and where the marketing outruns the research.

Strip it down and three points matter:

• The estrobolome does not make estrogen; it recycles what your body already produced.
• More enzyme activity points to more recycling, but human cause-and-effect is unproven.
• Nothing currently measures it well enough to guide a treatment decision.